NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹574 Cr | ₹323 Cr | ₹463 Cr | ₹272 Cr | ₹143 Cr |
What is the latest Operating Profit of NEULAND LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹574 Cr |
| Mar2025 | ₹323 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹272 Cr |
| Mar2022 | ₹143 Cr |
How is Operating Profit of NEULAND LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹574 Cr | 77.72 | |
| Mar2025 | ₹323 Cr | -30.12 | |
| Mar2024 | ₹463 Cr | 70.17 | |
| Mar2023 | ₹272 Cr | 90.61 | |
| Mar2022 | ₹143 Cr | - | |
Compare Operating Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,587.5 Cr | 0% | 1.9% | 28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0% |
1.9% |
28.5% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses